Bio Law Blog

Insights into IP and regulatory developments for biologic medicines.
Subscribe here for automatic updates to your inbox.

  • Welcome to the Bio Law Blog. Our blog shares insights into intellectual property law for biologic medicines and related regulatory and legislative developments. We started this blog to engage in a conversation about the rapidly developing U.S. biosimilars pathway (the Biologics Price Competition and Innovation Act) and the recent surge in approvals for cutting-edge biologic products, such as siRNAs and cell-based and gene therapies. These new biologic products are changing medicine and posing new intellectual property questions and challenges. We also analyze developments in written description and enablement law for antibodies, the impact of Section 101 on biotech discoveries, and the increasing role of the Patent Trial and Appeal Board in reviewing biotech patents. We share a perspective as trial lawyers immersed in biology and biotech patent law.

    We are excited to be part of these transformative times for biologic medicines and to discuss them with you. We hope you enjoy our blog, and we welcome any questions, comments or suggestions.

    Subscribe for updates here.

    Featured Posts

    • Bio Law Blog
      Aug. 15, 2024
      Less Is More — the Premise of the Biosimilar ‘Patent Thicket’ Bill
      Read More
    Show Filters

    Recent Posts

    • Bio Law Blog
      Aug. 15, 2024
      Less Is More — the Premise of the Biosimilar ‘Patent Thicket’ Bill
      Read More
    • Bio Law Blog
      July 19, 2024
      Just Opt Out! Boehringer Ingelheim’s IRA Challenge Is Latest To Fail
      Read More
    • Bio Law Blog
      May 01, 2024
      Potential Effects of the Inflation Reduction Act on Orphan Drug Development
      Read More
    • Bio Law Blog
      Nov. 30, 2020
      Third-Generation Vaccines Take Center Stage in Battle Against COVID-19
      Read More
    • Bio Law Blog
      July 01, 2020
      In Two Life Sciences Cases, the Supreme Court Declines to Address the Constitutionality of IPRs of Pre-AIA Patents
      Read More
    • Bio Law Blog
      May 01, 2020
      10 Years of Biosimilars: Lessons and Trends
      Read More

    Featured Perspectives

    • Announcements
      July 28, 2021
      Lisa Kobialka Named to Managing IP's 2021 Top 250 Women in IP List
      Read More
    • Announcements
      June 01, 2021
      Hannah Lee, Josh Winefsky Named Law360 Rising Stars
      Read More

    Editors

  • People

  • Perspectives

    See Related Results In:

    Perspectives

    • Announcements
      Nov. 12, 2024
      Jennifer L. Gilbert Receives 2024 Minority Bar Coalition Unity Award
      Read More
    • Announcements
      Oct. 24, 2024
      2024 New York Super Lawyers and Rising Stars Lists Include Over 90 Kramer Levin Attorneys
      Read More
    • Media Mentions
      Oct. 23, 2024
      AmLaw Litigation Daily Interview: How Kramer Levin's Patent Trial Team Approaches Teaching Tech to Juries
      Read More
    • Announcements
      Oct. 07, 2024
      Kramer Levin Team Named to Law360's "Legal Lions of the Week" List
      Read More
    • Announcements
      Oct. 03, 2024
      Benchmark Litigation 2025 Recognizes Kramer Levin
      Read More
    • Defining Matters
      Sept. 27, 2024
      Kramer Levin Secures $30.5 Million Jury Verdict on Behalf of Acceleration Bay
      Read More
    • Client Alerts
      Fall 2024
      Artificial Intelligence Quarterly Update
      Read More
    • Media Mentions
      May 10, 2024
      Kramer Levin Acceleration Bay Trial Team Named “Runners-up” in Litigation Daily’s Litigator of the Week
      Read More
    • Defining Matters
      May 06, 2024
      Kramer Levin Secures $23.4M Patent Infringement Verdict on Behalf of Acceleration Bay
      Read More

    Events

    • Speaking Engagement
      Nov. 20, 2024
      CenterForce: Maximizing Value: IP Enforcement & Monetization Strategies
      Read More
    • Speaking Engagement
      Nov. 12, 2024
      CenterForce: Maximizing Value: IP Enforcement & Monetization Strategies
      Read More
    • Speaking Engagement
      Sept. 10, 2024
      JPPCLE: Brumfield v. IBG LLC
      Read More
    • Speaking Engagement
      May 29, 2024
      ACI’s 22nd Advanced Summit on Life Sciences Patents
      Read More
    • Speaking Engagement
      March 20, 2024
      American Conference Institute’s 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
      Read More
    • Speaking Engagement
      Nov. 01, 2023
      Centerforce’s IP Strategy Summit - 2023
      Read More
    • Speaking Engagement
      Oct. 25, 2023
      Centerforce’s IP Strategy Summit
      Read More
    • Sponsorship
      Sept. 10, 2023
      Intellectual Property Owners Association’s 2023 Annual Meeting
      Read More
    • Speaking Engagement
      June 27, 2023
      American Conference Institute’s Biosimilars & Innovator Biologics 2023
      Read More

Connect with us.

Subscribe here

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.